loadpatents
name:-0.053651809692383
name:-0.01417088508606
name:-0.021852016448975
Fondation Imagine Patent Filings

Fondation Imagine

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fondation Imagine.The latest application filed is for "a neuropilin antagonist in combination with a p38alpha-kinase inhibitor for the treatment of cancer".

Company Profile
18.18.38
  • Fondation Imagine - Paris FR
  • Fondation Imagine - Paris Cedex 15 FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
A Neuropilin Antagonist In Combination With A P38alpha-kinase Inhibitor For The Treatment Of Cancer
App 20220307021 - LEPELLETIER; Yves ;   et al.
2022-09-29
Methods For Inducing Full Ablation Of Hematopoiesis
App 20220265781 - LAGRESLE-PEYROU; Chantal ;   et al.
2022-08-25
Methods and pharmaceutical compositions for the treatment of mast cell diseases
Grant 11,389,434 - Maouche-Chretien , et al. July 19, 2
2022-07-19
Use Of Jak Inhibitors For The Treatment Of Painful Conditions Involving Nav1.7 Channels
App 20220202820 - BODEMER; Christine ;   et al.
2022-06-30
Nrp-1 Binding Inhibitory Peptides And Uses Thereof
App 20220169677 - Lepelletier; Yves ;   et al.
2022-06-02
Methods Of Inducing Or Restoring Immune Tolerance
App 20220168394 - ANDRE; Isabelle ;   et al.
2022-06-02
Bifunctional Vectors Allowing Bcl11a Silencing And Expression Of An Anti-sickling Hbb And Uses Thereof For Gene Therapy Of B-hemoglobinopathies
App 20220160788 - MICCIO; Annarita ;   et al.
2022-05-26
Recombinant Vectors Suitable For The Treatment Of Ipex Syndrome
App 20220136006 - ANDRE; Isabelle ;   et al.
2022-05-05
Treatment And Prediction Of Therapeutic Responses In Patients Suffering From Friedreich Ataxia
App 20220105073 - ROTIG; Anne Agnes ;   et al.
2022-04-07
Methods And Pharmaceutical Compositions For Enhancing Cd8+ T Cell-dependent Immune Responses In Subjects Suffering From Cancer
App 20220073626 - HERMINE; Olivier ;   et al.
2022-03-10
Infigratinib For Treatment Of Fgfr3-related Skeletal Diseases During Pregnancy
App 20220040175 - LEGEAI-MALLET; Laurence
2022-02-10
Methods For Increasing Fetal Hemoglobin Content In Eukaryotic Cells And Uses Thereof For The Treatment Of Hemoglobinopathies
App 20220033856 - MICCIO; Annarita ;   et al.
2022-02-03
Recombinant Vectors Suitable For The Treatment Of Ipex Syndrome
App 20220017919 - ANDRE; Isabelle ;   et al.
2022-01-20
Egfr Inhibitors For Treating Keratodermas
App 20210393632 - BODEMER; Christine ;   et al.
2021-12-23
Methods And Pharmaceutical Compositions For The Treatment Of Systemic Mastocytosis
App 20210308106 - HERMINE; Olivier ;   et al.
2021-10-07
Methods and pharmaceutical compositions for the treatment of systemic mastocytosis
Grant 11,065,230 - Hermine , et al. July 20, 2
2021-07-20
Methods And Pharmaceutical Compositions For Inhibiting T Cell Proliferation In A Subject In Need Thereof
App 20210116458 - LATOUR; Sylvain ;   et al.
2021-04-22
Methods For Determining Whether A Patient Suffering From Rhabdomyolysis Achieves A Response With A Tlr9 Antagonist
App 20210087633 - DE LONLAY-DEBENEY; Pascale ;   et al.
2021-03-25
Methods And Pharmaceutical Compositions For The Treatment Of Fgfr3-related Chondrodysplasias
App 20210052546 - LEGEAI-MALLET; Laurence ;   et al.
2021-02-25
Methods and pharmaceutical compositions for the treatment of neurodegeneration with brain iron accumulation
Grant 10,874,637 - Rotig , et al. December 29, 2
2020-12-29
Methods and pharmaceutical compostions for treating rhabdomyolysis
Grant 10,653,687 - De Lonlay-Debeney , et al.
2020-05-19
Polypeptides capable of inhibiting the binding between leptin and Neuropilin-1
Grant 10,647,752 - Belaid-Choucair , et al.
2020-05-12
Methods And Pharmaceutical Compositions For The Treatment Of Olmsted Syndrome
App 20200129486A1 -
2020-04-30
Methods And Pharmaceutical Compositions For The Treatment Of Neurodegeneration With Brain Iron Accumulation
App 20200113868A1 -
2020-04-16
Methods And Pharmaceutical Compositions For The Treatment Of Mast Cell Diseases
App 20200108053A1 -
2020-04-09
Method Of Culturing Segmented Filamentous Bacteria In Vitro
App 20190367867 - EBERL; Gerard ;   et al.
2019-12-05
Method of culturing segmented filamentous bacteria in vitro
Grant 10,435,665 - Gerard , et al. O
2019-10-08
Methods And Pharmaceutical Compositions For The Treatment Of Systemic Mastocytosis
App 20190247416 - HERMINE; Olivier ;   et al.
2019-08-15
Methods And Vaccine Compositions For The Treatment Of B-cell Malignancies
App 20190157728 - LATOUR; Sylvain ;   et al.
2019-05-23
Methods And Pharmaceutical Composition For The Treatment Of Inflammatory Skin Diseases Associated With Desmoglein-1 Deficiency
App 20190125826 - BODEMER; Christine ;   et al.
2019-05-02
Methods For Performing Antisense Oligonucleotide-mediated Exon Skipping In The Retina Of A Subject In Need Thereof
App 20190037583 - ROZET; Jean-Michel ;   et al.
2019-01-31
Methods and Pharmaceutical Compositions for the Treatment of Diseases Mediated by the NRP-1/OBR Complex Signaling Pathway
App 20190002569 - Belaid-Choucair; Zakia ;   et al.
2019-01-03
Methods And Pharmaceutical Compositions For The Treatment Of Darier Disease
App 20180353486 - Hovnanian; Alain ;   et al.
2018-12-13
Methods And Pharmaceutical Compostions For Treating Rhabdomyolysis
App 20180325890 - DE LONLAY-DEBENEY; Pascale ;   et al.
2018-11-15
Composition comprising a combination of DNA methylation inhibitor and a vitamin D receptor agonist for the treatment of drug resistant cancer or for the prevention of tumor relapse
Grant 10,111,896 - Cruz-Moura , et al. October 30, 2
2018-10-30
Fgfr3 Antagonists
App 20180237424 - LEGEAI-MALLET; Laurence ;   et al.
2018-08-23
Polypeptides Capable of Inhibiting the Binding Between Leptin and Neuropilin-1
App 20180230189 - Belaid-Choucair; Zakia ;   et al.
2018-08-16
Methods And Pharmaceutical Compositions For Inhibiting Lymphocyte Proliferation In A Subject In Need Thereof
App 20180185476 - LATOUR; Sylvain ;   et al.
2018-07-05
Methods For Predicting The Responsiveness Of A Patient Affected With Malignant Hematological Disease To Chemotherapy Treatment And Methods Of Treatment Of Such Disease
App 20180031579 - CRUZ-MOURA; Ivan ;   et al.
2018-02-01
Methods and pharmaceutical compositions for the treatment of beta-thalassemias
Grant 9,861,615 - Hermine , et al. January 9, 2
2018-01-09
Method Of Culturing Segmented Filamentous Bacteria In Vitro
App 20170335276 - Gerard; EBERL ;   et al.
2017-11-23
Methods and pharmaceutical compositions for the treatment of myelodysplastic syndromes
Grant 9,675,590 - Hermine , et al. June 13, 2
2017-06-13
Composition Comprising a Combination of DNA Methylation Inhibitor and a Vitamin D Receptor Agonist for the Treatment of Drug Resistant Cancer or for the Prevention of Tumor Relapse
App 20170119804 - Cruz-Moura; Ivan ;   et al.
2017-05-04
Methods And Pharmaceutical Compositions For The Treatment Of Myelodysplastic Syndromes
App 20170100378 - HERMINE; Olivier
2017-04-13
Methods and Pharmaceutical Compositions for the Treatment of Diseases Mediated by the NRP-1/OBR Complex Signaling Pathway
App 20170051062 - Belaid-Choucair; Zakia ;   et al.
2017-02-23
Methods And Pharmaceutical Compositions For The Treatment Of Beta-thalassemias
App 20170020847 - HERMINE; Olivier ;   et al.
2017-01-26
Methods And Compositions For The Treatment Of Beta-thalassemia
App 20160368975 - HERMINE; Olivier ;   et al.
2016-12-22
Methods and compositions for the treatment of .beta.-thalassemia
Grant 9,377,471 - Hermine , et al. June 28, 2
2016-06-28
Methods And Pharmaceutical Compositions (ctps 1 Inhibitors, E.g. Norleucine) For Inhibiting T Cell Proliferation In A Subject In Need Thereof
App 20160051674 - LATOUR; Sylvain ;   et al.
2016-02-25
Methods And Compositions For The Treatment Of Beta-thalassemia
App 20150141341 - HERMINE; Olivier ;   et al.
2015-05-21
Method For Diagnosing A Skeletal Ciliopathy
App 20150106960 - Cormier-Daire; Valerie ;   et al.
2015-04-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed